Tuesday - September 15, 2026
Holland & Knight Advises Saol Therapeutics on Strategic Investment of Up to $115 Million from Oaktree Capital Management
September 15, 2026
MIAMI, Florida, Sept. 15 [Category: BizLaw/Legal] -- Holland and Knight, a law firm, posted the following news release:

* * *

Holland & Knight Advises Saol Therapeutics on Strategic Investment of Up to $115 Million from Oaktree Capital Management

*

DALLAS (September 15, 2026) - Holland & Knight represented Saol Therapeutics, a privately held, clinical-stage pharmaceutical company, in its definitive agreement under which funds managed by . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products

Click here for more information about our products